Infrared illumination for difficult peripheral venous catheterisation in critically ill adult patients: the prospective, randomised, multicentre ICARE trial

医学 重症监护医学 随机对照试验 外科 急诊医学
作者
R. Ouedraogo,Aline da Silva Alves,Amélie Bruant,Oumar Sy,Cécilia Tabra Osorio,Frédérique Schortgen,Amélie Chenal,Damien Contou,Laurence Krzyzaniak,Muriel Fartoukh,Marianne Le Joncour,Nicolas Mongardon,L. Benaïssa,Daniel Da Silva,Meriem Bouguerra,Sophie Demeret,Stéphanie Dubois,Eric Starczala,Chirine Petyt,Matthieu Schmidt,Séverine Dezellus,Jean Francois Georger,Ann-Cécile Pallud,Damien Carras,Fabien Boussely,Étienne Audureau,Armand Mekontso Dessap
出处
期刊:BMJ Open [BMJ]
卷期号:15 (2): e090611-e090611
标识
DOI:10.1136/bmjopen-2024-090611
摘要

Introduction The insertion of a peripheral venous line is of paramount importance in the stabilisation of critically ill patients. It is a preferred method of venous access over more invasive techniques due to its immediacy and fewer complications. Difficulties of catheterisation can result in delays to treatment, increased complication risks and pain, and a waste of valuable time and healthcare resources. Our hypothesis is that infrared vein illumination could improve the success rate of peripheral venous catheterisation in critically ill patients at risk of difficult catheterisation. Methods and analysis This is a prospective, multicentre, randomised, open-label controlled trial. It will be conducted in France and will involve critically ill patients at risk of difficult peripheral catheterisation. Patients will be randomly assigned to usual care or infrared vein illumination. The primary outcome is the rate of successful peripheral venous catheterisation at first puncture. Secondary outcomes include time to placement, overall rate of successful peripheral venous catheterisation, number of punctures, quality (calibre of the catheter), replacement rate, need for central line and local complications (dysfunction, diffusion, haematoma and lymphangitis). Ethics and dissemination The study has been granted ethical approval (CPP Ile de France 1). Following the provision of informed consent, patients will be included in the study. The results will be submitted for publication in peer-reviewed journals. Trial registration number NCT03932214 .

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
星辰大海的应助被qq采纳,获得10
刚刚
思源的应助被科研通管家采纳,获得10
1秒前
1秒前
英姑的应助被科研通管家采纳,获得10
1秒前
2秒前
情怀的应助被科研通管家采纳,获得10
2秒前
充电宝的应助被科研通管家采纳,获得10
2秒前
JamesPei的应助被科研通管家采纳,获得10
2秒前
科研通AI2S的应助被科研通管家采纳,获得10
2秒前
平常的元蝶完成签到 ,获得积分10
3秒前
NN发布了新的文献求助10
3秒前
3秒前
3秒前
南宫誉发布了新的文献求助10
4秒前
zz完成签到,获得积分10
4秒前
4秒前
闪闪的小笼包完成签到,获得积分20
5秒前
6秒前
7秒前
忆年完成签到 ,获得积分10
7秒前
WXR0721发布了新的文献求助10
7秒前
桐桐的应助被XIANYU采纳,获得10
8秒前
zhs发布了新的文献求助10
8秒前
多吃不胖发布了新的文献求助20
9秒前
pluto的应助被绵绵棉采纳,获得10
9秒前
NN完成签到,获得积分10
10秒前
皮皮团完成签到 ,获得积分10
10秒前
搜集达人的应助被小锤采纳,获得10
10秒前
Akim的应助被无一采纳,获得10
11秒前
RON发布了新的文献求助10
13秒前
geagra完成签到,获得积分10
14秒前
Akim的应助被天下无双采纳,获得10
14秒前
15秒前
15秒前
Iridescent完成签到 ,获得积分10
15秒前
雨安完成签到,获得积分10
15秒前
小图发布了新的文献求助10
16秒前
16秒前
17秒前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Rosenblum, Global Change Biology 800
Computational Chemical Reaction Engineering: Modeling, Simulation, and Design with MATLAB 600
Organizational Behavior 510
Management and the Arts 510
Production Logging: Theoretical and Interpretive Elements 400
CLSI C56QG Examples of Hemolyzed, Icteric, and Lipemic/Turbid Samples Quick Guide 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 内科学 物理 有机化学 化学工程 生物化学 复合材料 光电子学 细胞生物学 心理学 量子力学 催化作用 物理化学 电极
热门帖子
关注 科研通微信公众号,转发送积分 7814451
求助须知:如何正确求助?哪些是违规求助? 9344577
关于积分的说明 20524484
捐赠科研通 7407359
什么是DOI,文献DOI怎么找? 3330803
关于科研通互助平台的介绍 2477276
邀请新用户注册赠送积分活动 2350387